Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 897

1.

A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.

Imura C, Ueyama A, Sasaki Y, Shimizu M, Furue Y, Tai N, Tsujii K, Katayama K, Okuno T, Shichijo M, Yasui K, Yamamoto M.

J Dermatol Sci. 2019 Mar 8. pii: S0923-1811(19)30067-2. doi: 10.1016/j.jdermsci.2019.03.002. [Epub ahead of print]

PMID:
30905492
2.

Metabolic regulation of TH17 cells.

Shen H, Shi LZ.

Mol Immunol. 2019 Mar 20;109:81-87. doi: 10.1016/j.molimm.2019.03.005. [Epub ahead of print]

PMID:
30903829
3.

Cis-khellactone inhibited the proinflammatory macrophages via promoting autophagy to ameliorate imiquimod-induced psoriasis.

Feng L, Song P, Xu F, Xu L, Shao F, Guo M, Huang W, Kong L, Wu X, Xu Q.

J Invest Dermatol. 2019 Mar 13. pii: S0022-202X(19)31316-8. doi: 10.1016/j.jid.2019.02.021. [Epub ahead of print]

PMID:
30878677
4.

[Study on clinical efficacy and mechanism of Qingying Tang for treating psoriatic blood-heat syndrome based on IL-23/Th17].

Wang L, Fang YP, Zhou GX, Wu PH, Li QJ, Geng QN.

Zhongguo Zhong Yao Za Zhi. 2019 Jan;44(1):175-180. doi: 10.19540/j.cnki.cjcmm.20180709.001. Chinese.

PMID:
30868829
5.

Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris.

Strohbuecker L, Koenen H, van Rijssen E, van Cranenbroek B, Fasse E, Joosten I, Körber A, Bergmann C.

Psoriasis (Auckl). 2019 Feb 12;9:7-17. doi: 10.2147/PTT.S190507. eCollection 2019.

6.

Indole alkaloids indigodoles A-C from aerial parts of Strobilanthes cusia in the traditional Chinese medicine Qing Dai have anti-IL-17 properties.

Lee CL, Wang CM, Hu HC, Yen HR, Song YC, Yu SJ, Chen CJ, Li WC, Wu YC.

Phytochemistry. 2019 Mar 7;162:39-46. doi: 10.1016/j.phytochem.2019.02.016. [Epub ahead of print]

PMID:
30852259
7.

The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells.

Gianello V, Salvi V, Parola C, Moretto N, Facchinetti F, Civelli M, Villetti G, Bosisio D, Sozzani S.

Biochem Pharmacol. 2019 Mar 6;163:371-380. doi: 10.1016/j.bcp.2019.03.006. [Epub ahead of print]

PMID:
30851246
8.

Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model.

Stehlikova Z, Kostovcikova K, Kverka M, Rossmann P, Dvorak J, Novosadova I, Kostovcik M, Coufal S, Srutkova D, Prochazkova P, Hudcovic T, Kozakova H, Stepankova R, Rob F, Juzlova K, Hercogova J, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z.

Front Microbiol. 2019 Feb 21;10:236. doi: 10.3389/fmicb.2019.00236. eCollection 2019.

9.

Proteomics in Psoriasis.

Chularojanamontri L, Charoenpipatsin N, Silpa-Archa N, Wongpraparut C, Thongboonkerd V.

Int J Mol Sci. 2019 Mar 6;20(5). pii: E1141. doi: 10.3390/ijms20051141. Review.

10.

Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice.

Shin SH, Cho KA, Hahn S, Lee Y, Kim YH, Woo SY, Ryu KH, Park WJ, Park JW.

Acta Derm Venereol. 2019 Mar 5. doi: 10.2340/00015555-3160. [Epub ahead of print]

11.

Human Embryonic Stem Cells-Derived Mesenchymal Stem Cells Reduce the Symptom of Psoriasis in Imiquimod-Induced Skin Model.

Kim CH, Lim CY, Lee JH, Kim KC, Ahn JY, Lee EJ.

Tissue Eng Regen Med. 2018 Dec 1;16(1):93-102. doi: 10.1007/s13770-018-0165-3. eCollection 2019 Feb.

PMID:
30815354
12.

Psoriatic Synovitis: Singularity and Potential Clinical Implications.

Celis R, Cuervo A, Ramírez J, Cañete JD.

Front Med (Lausanne). 2019 Feb 11;6:14. doi: 10.3389/fmed.2019.00014. eCollection 2019. Review.

13.

Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.

Das D, Akhtar S, Kurra S, Gupta S, Sharma A.

Cytokine Growth Factor Rev. 2019 Feb;45:35-44. doi: 10.1016/j.cytogfr.2019.01.001. Epub 2019 Feb 8. Review.

PMID:
30773437
14.

Clinical significance and immunobiology of IL-21 in autoimmunity.

Long D, Chen Y, Wu H, Zhao M, Lu Q.

J Autoimmun. 2019 Feb 14. pii: S0896-8411(19)30049-6. doi: 10.1016/j.jaut.2019.01.013. [Epub ahead of print] Review.

PMID:
30773373
15.

Exopolysaccharides from Cyanobacterium aponinum induce a regulatory dendritic cell phenotype and inhibit SYK and CLEC7A expression in dendritic cells, T cells and keratinocytes.

Gudmundsdottir AB, Brynjolfsdottir A, Olafsdottir ES, Hardardottir I, Freysdottir J.

Int Immunopharmacol. 2019 Apr;69:328-336. doi: 10.1016/j.intimp.2019.01.044. Epub 2019 Feb 15.

PMID:
30772700
16.

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence.

Storelli E, Cassina N, Rasini E, Marino F, Cosentino M.

Front Neurol. 2019 Jan 24;10:13. doi: 10.3389/fneur.2019.00013. eCollection 2019. Review.

17.

JAK/STAT inhibitors for the treatment of atopic dermatitis.

Rodrigues MA, Torres T.

J Dermatolog Treat. 2019 Jan 31:1-8. doi: 10.1080/09546634.2019.1577549. [Epub ahead of print]

PMID:
30703333
18.

Role of Galphaq in pathogenesis of psoriasis, a new mechanism about the immune regulation in psoriasis.

Qian H, Wang M, Wang Y, Ying W, Zhang J, Huan Y, He Y, Liu Y, Shi G.

Int Immunopharmacol. 2019 Mar;68:185-192. doi: 10.1016/j.intimp.2018.12.054. Epub 2019 Jan 15.

PMID:
30654308
19.

Clinical and Genetic Aspects of Behçet's Disease in Japan.

Kirino Y, Nakajima H.

Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2035-18. [Epub ahead of print]

20.

Altered expression of regulatory molecules in the skin of psoriasis.

Sabag AD, Dias-Polak D, Bejar J, Sheffer H, Bergman R, Vadasz Z.

Immunol Res. 2019 Jan 7. doi: 10.1007/s12026-018-9057-9. [Epub ahead of print]

PMID:
30613859

Supplemental Content

Loading ...
Support Center